Paper27246772
Minoxidil for Treatment of Resistant Hypertension in Chronic Kidney Disease--A Retrospective Cohort Analysis.
Mundt HM and 6 others. J Clin Hypertens (Greenwich), 2016. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Minoxidil for Treatment of Resistant Hypertension in Chronic Kidney Disease--A Retrospective Cohort Analysis. Papers, record 27246772. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27246772
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Minoxidil for Treatment of Resistant Hypertension in Chronic Kidney Disease--A Retrospective Cohort Analysis.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antihypertensive Agents | Major topic |
| Hypertension | Major topic |
| Minoxidil | Major topic |
| Renal Insufficiency, Chronic | Major topic |
| Aged | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Inpatients | |
| Male | |
| Middle Aged | |
| Retrospective Studies | |
| Treatment Outcome |
Source PubMed
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7089494 | Clinical experience of long-term treatment with minoxidil in severe arterial hypertension. | Scand J Urol Nephrol | 1982 | https://conductscience.org/library/papers/7089494 | PubMed |
| 2 | 2856769 | Felodipine can replace minoxidil in the treatment of refractory hypertension. | J Hypertens Suppl | 1985 | https://conductscience.org/library/papers/2856769 | PubMed |
| 3 | 23771844 | 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). | Eur Heart J | 2013 | https://conductscience.org/library/papers/23771844 | PubMed |
| 4 | 15133413 | Minoxidil: an underused vasodilator for resistant or severe hypertension. | J Clin Hypertens (Greenwich) | 2004 | https://conductscience.org/library/papers/15133413 | PubMed |
| 5 | 11677373 | High prevalence of cardiac and extracardiac target organ damage in refractory hypertension. | J Hypertens | 2001 | https://conductscience.org/library/papers/11677373 | PubMed |
| 6 | 16891288 | Resistant hypertension: diagnosis and management. | J Cardiovasc Pharmacol Ther | 2006 | https://conductscience.org/library/papers/16891288 | PubMed |
| 7 | 95728 | Minoxidil in resistant hypertension. | Lancet | 1977 | https://conductscience.org/library/papers/95728 | PubMed |
| 8 | 21896152 | Direct-acting vasodilators. | J Clin Hypertens (Greenwich) | 2011 | https://conductscience.org/library/papers/21896152 | PubMed |
| 9 | 21272200 | Drug therapy for resistant hypertension: simplifying the approach. | J Clin Hypertens (Greenwich) | 2011 | https://conductscience.org/library/papers/21272200 | PubMed |
| 10 | 24231917 | Management of patients with resistant hypertension: current treatment options. | Integr Blood Press Control | 2013 | https://conductscience.org/library/papers/24231917 | PubMed |
| 11 | 6156351 | Long-term effects of minoxidil therapy on renal function of patients with refractory hypertension: the significance of albuminuria. | J Cardiovasc Pharmacol | 1980 | https://conductscience.org/library/papers/6156351 | PubMed |
| 12 | 21502568 | Prevalence of resistant hypertension in the United States, 2003-2008. | Hypertension | 2011 | https://conductscience.org/library/papers/21502568 | PubMed |
| 13 | 26765793 | Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease: Efficacy and Safety. | Blood Purif | 2016 | https://conductscience.org/library/papers/26765793 | PubMed |
| 14 | 603847 | Long-term treatment of severe hypertension with minoxidil. | Can Med Assoc J | 1977 | https://conductscience.org/library/papers/603847 | PubMed |
| 15 | 6753777 | Rapid control of severe hypertension with minoxidil. | Arch Intern Med | 1982 | https://conductscience.org/library/papers/6753777 | PubMed |
| 16 | 1827043 | Cardiac changes from beta-blocker, diuretic and minoxidil combination in hypertension. | Cardiology | 1991 | https://conductscience.org/library/papers/1827043 | PubMed |
| 17 | 346 | Treatment of severe hypertension with minoxidil. | Isr J Med Sci | 1975 | https://conductscience.org/library/papers/346 | PubMed |
| 18 | 4391708 | Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade. | N Engl J Med | 1970 | https://conductscience.org/library/papers/4391708 | PubMed |
| 19 | 6111848 | Minoxidil in combination with a beta-adrenergic blocker and a diuretic as an antihypertensive in patients refractory to available medications. | S Afr Med J | 1981 | https://conductscience.org/library/papers/6111848 | PubMed |
| 20 | 2906371 | Nifedipine substituted for minoxidil in the treatment of refractory hypertension. | J Hum Hypertens | 1987 | https://conductscience.org/library/papers/2906371 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42483492 | A Comprehensive Review on the Efficacy of Antihypertensives in Patients With End-Stage Renal Disease. | Int J Hypertens | 2026 | https://conductscience.org/library/papers/42483492 | PubMed |
| 40097761 | Potential Risks of Minoxidil in Pheochromocytoma and Paraganglioma: A Commentary on Safety Concerns and Mechanisms. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/40097761 | PubMed |
| 40009791 | I Brazilian guideline on hypertension in dialysis of the Brazilian Society of Nephrology. | J Bras Nefrol | 2025 | https://conductscience.org/library/papers/40009791 | PubMed |
| 38623369 | Topical minoxidil reported hair discoloration: a cross-sectional study. | Dermatol Reports | 2024 | https://conductscience.org/library/papers/38623369 | PubMed |
| 32796537 | Towards the Development of AgoKirs: New Pharmacological Activators to Study Kir2.x Channel and Target Cardiac Disease. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32796537 | PubMed |
| 31792659 | [Austrian Consensus on High Blood Pressure 2019]. | Wien Klin Wochenschr | 2019 | https://conductscience.org/library/papers/31792659 | PubMed |
| 29892833 | Treatment of Hypertension in Chronic Kidney Disease. | Curr Hypertens Rep | 2018 | https://conductscience.org/library/papers/29892833 | PubMed |
| 28597403 | Resistant Hypertension: Mechanisms and Treatment. | Curr Hypertens Rep | 2017 | https://conductscience.org/library/papers/28597403 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/27246772
GET https://conductscience.org/api/papers/v1/27246772/references?page=2